Advertisement
Clinical Research|Articles in Press

Cost-effectiveness Analysis of Open versus Endovascular Revascularization for Chronic Mesenteric Ischemia

Published:March 03, 2023DOI:https://doi.org/10.1016/j.avsg.2023.02.013

      Abstract:

      Objectives

      Recent studies have shown a trend supporting endovascular revascularization (ER) in the treatment of chronic mesenteric ischemia (CMI). However, few studies have compared the cost effectiveness of ER and open revascularization (OR) for this indication. The purpose of this study is to conduct a cost-effectiveness analysis comparing open versus endovascular revascularization for CMI.

      Methods

      We built a Markov model with Monte Carlo microsimulation using transition probabilities and utilities from existing literature for CMI patients undergoing OR versus ER. Costs were derived from the hospital perspective using the 2020 Medicare Physician Fee Schedule. The model randomized 20,000 patients to either OR or ER and allowed for one subsequent reintervention with three other intervening health states: alive, alive with complications, and dead. Quality adjusted life years (QALYs), costs, and incremental cost-effectiveness ratio (ICER) were analyzed over a five-year period. One-way sensitivity and probabilistic sensitivity analyses were conducted to study the impact of parameter variability on cost effectiveness.

      Results

      OR cost $4532 for 1.03 QALYs while ER cost $5092 for 1.21 QALYs, leading to an ICER of $3037 per QALY gained in the ER arm. This ICER was less than our willingness to pay threshold of $100,000. Sensitivity analysis demonstrated that our model was most sensitive to costs, mortality, and patency rates after OR and ER. Probabilistic sensitivity analysis demonstrated ER would be considered cost effective 99% of iterations.

      Conclusions

      This study found that while five-year costs for ER were greater than OR, ER afforded greater QALYs than OR. Although ER is associated with lower long-term patency and higher rates of reintervention, it appears to be more cost effective than OR for the treatment of CMI.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References:

        • Järvinen O
        • Laurikka J
        • Sisto T
        • Salenius JP
        • Tarkka MR
        Atherosclerosis of the visceral arteries.
        VASA Z Gefasskrankheiten. 1995; 24: 9-14
        • Terlouw LG
        • Verbeten M
        • van Noord D
        • Brusse-Keizer M
        • Beumer RR
        • Geelkerken RH
        • Bruno MJ
        • Kolkman JJ
        • Dutch Mesenteric Ischemia Study Group
        The Incidence of Chronic Mesenteric Ischemia in the Well-Defined Region of a Dutch Mesenteric Ischemia Expert Center.
        Clin Transl Gastroenterol. 2020; 11e00200
        • Zeller T
        • Rastan A
        • Sixt S
        Chronic atherosclerotic mesenteric ischemia (CMI).
        Vasc Med Lond Engl. 2010; 15: 333-338
        • Blauw JTM
        • Pastoors HAM
        • Brusse-Keizer M
        • Beuk RJ
        • Kolkman JJ
        • Geelkerken RH
        For The Dutch Mesenteric Ischemia Study Group. The Impact of Revascularisation on Quality of Life in Chronic Mesenteric Ischemia.
        Can J Gastroenterol Hepatol. 2019 Nov 12; 20197346013
        • Shaw RS
        • Maynard EP
        Acute and chronic thrombosis of the mesenteric arteries associated with malabsorption; a report of two cases successfully treated by thromboendarterectomy.
        N Engl J Med. 1958; 258: 874-878
        • Schermerhorn ML
        • Giles KA
        • Hamdan AD
        • Wyers MC
        • Pomposelli FB
        Mesenteric revascularization: management and outcomes in the United States, 1988-2006.
        J Vasc Surg. 2009; 50: 341-348.e1
        • Oderich GS
        • Gloviczki P
        • Bower TC
        Open surgical treatment for chronic mesenteric ischemia in the endovascular era: when it is necessary and what is the preferred technique?.
        Semin Vasc Surg. 2010; 23: 36-46
        • Huber TS
        • Björck M
        • Chandra A
        • Clouse WD
        • Dalsing MC
        • Oderich GS
        • Smeds MR
        • Murad MH
        Chronic mesenteric ischemia: Clinical practice guidelines from the Society for Vascular Surgery.
        J Vasc Surg. 2021 Jan; 73: 87S-115S
        • Mitchell EL
        The Society for Vascular Surgery clinical practice guidelines define the optimal care of patients with chronic mesenteric ischemia.
        J Vasc Surg. 2021; 73: 84S-86S
        • Oderich GS
        • Bower TC
        • Sullivan TM
        • Bjarnason H
        • Cha S
        • Gloviczki P
        Open versus endovascular revascularization for chronic mesenteric ischemia: risk-stratified outcomes.
        J Vasc Surg. 2009; 49: 1472-1479.e3
        • Cai W
        • Li X
        • Shu C
        • Qiu J
        • Fang K
        • Li M
        • Chen Y
        • Liu D
        Comparison of clinical outcomes of endovascular versus open revascularization for chronic mesenteric ischemia: a meta-analysis.
        Ann Vasc Surg. 2015 Jul; 29: 934-940
        • Gurakar M
        • Locham S
        • Alshaikh HN
        • Malas MB
        Risk factors and outcomes for bowel ischemia after open and endovascular abdominal aortic aneurysm repair.
        J Vasc Surg. 2019 Sep; 70: 869-881
        • Tallarita T
        • Oderich GS
        • Gloviczki P
        • Duncan AA
        • Kalra M
        • Cha S
        • Misra S
        • Bower TC
        Patient survival after open and endovascular mesenteric revascularization for chronic mesenteric ischemia.
        J Vasc Surg. 2013 Mar; 57: 747-755
        • Alahdab F
        • Arwani R
        • Pasha AK
        • Razouki ZA
        • Prokop LJ
        • Huber TS
        • Murad MH
        A systematic review and meta-analysis of endovascular versus open surgical revascularization for chronic mesenteric ischemia.
        J Vasc Surg. 2018 May; 67: 1598-1605
        • Lima FV
        • Kolte D
        • Kennedy KF
        • Louis DW
        • Abbott JD
        • Soukas PA
        • Hyder ON
        • Mamdani ST
        • Aronow HD
        Endovascular Versus Surgical Revascularization for Chronic Mesenteric Ischemia: Insights From the National Inpatient Sample Database.
        JACC Cardiovasc Interv. 2017 Dec; 10: 2440-2447
        • Erben Y
        • Jean RA
        • Protack CD
        • Chiu AS
        • Liu S
        • Sumpio BJ
        • Miller SM
        • Sumpio BE
        Improved mortality in treatment of patients with endovascular interventions for chronic mesenteric ischemia.
        J Vasc Surg. 2018 Jun; 67: 1805-1812
        • Finlayson SR
        • Birkmeyer JD
        Cost-effectiveness analysis in surgery.
        Surgery. 1998; 123: 151-156
        • Brooke BS
        • Kaji AH
        • Itani KMF
        Practical Guide to Cost-effectiveness Analysis.
        JAMA Surg. 2020; 155: 250-251
        • Hogendoorn W
        • Hunink MGM
        • Schlösser FJV
        • Moll FL
        • Muhs BE
        • Sumpio BE
        A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model.
        J Vasc Surg. 2014; 60: 715-725
        • Stroupe KT
        • Lederle FA
        • Matsumura JS
        • Kyriakides TC
        • Jonk YC
        • Ge L
        • Freischlag JA
        Open Versus Endovascular Repair (OVER) Veterans Affairs Cooperative Study Group. Cost-effectiveness of open versus endovascular repair of abdominal aortic aneurysm in the OVER trial.
        J Vasc Surg. 2012 Oct; 56: 901-909.e2
        • Skelly CL
        • Stiles-Shields C
        • Mak GZ
        • Speaker CR
        • Lorenz J
        • Anitescu M
        • Dickerson DM
        • Boyd H
        • O’Brien S
        • Drossos T
        The impact of psychiatric comorbidities on patient-reported surgical outcomes in adults treated for the median arcuate ligament syndrome.
        J Vasc Surg. 2018 Nov; 68: 1414-1421
        • Wagenhäuser MU
        • Meyer-Janiszewski YK
        • Dueppers P
        • Spin JM
        • Floros N
        • Schelzig H
        • Duran M
        Chronic Mesenteric Ischemia: Patient Outcomes Using Open Surgical Revascularization.
        Dig Surg. 2017; 34: 340-349
        • Coughlin PA
        • Jackson D
        • White AD
        • Bailey MA
        • Farrow C
        • Scott DJ
        • Howell SJ
        Meta-analysis of prospective trials determining the short- and mid-term effect of elective open and endovascular repair of abdominal aortic aneurysms on quality of life.
        Br J Surg. 2013 Mar; 100: 448-455
        • Kayssi A
        • DeBord Smith A
        • Roche-Nagle G
        • Nguyen LL
        Health-related quality-of-life outcomes after open versus endovascular abdominal aortic aneurysm repair.
        J Vasc Surg. 2015 Aug; 62: 491-498
        • Obeid T
        • Alshaikh H
        • Nejim B
        • Arhuidese I
        • Locham S
        • Malas M
        Fixed and variable cost of carotid endarterectomy and stenting in the United States: A comparative study.
        J Vasc Surg. 2017 May; 65: 1398-1406.e1
        • Dakour-Aridi H
        • Nejim B
        • Locham S
        • Alshaikh H
        • Obeid T
        • Malas MB
        Complication-Specific In-Hospital Costs After Carotid Endarterectomy vs Carotid Artery Stenting.
        J Endovasc Ther. 2018 Aug; 25: 514-521
        • Gupta AK
        • Alshaikh HN
        • Dakour-Aridi H
        • King RW
        • Brothers TE
        • Malas MB
        Real-world cost analysis of endovascular repair versus open repair in patients with nonruptured abdominal aortic aneurysms.
        J Vasc Surg. 2020 Feb; 71: 432-443.e4
        • Cooper JT
        • Lloyd A
        • Sanchez JJG
        • Sörstadius E
        • Briggs A
        • McFarlane P
        Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review.
        Health Qual Life Outcomes. 2020 Sep 21; 18: 310
        • Jesky MD
        • Dutton M
        • Dasgupta I
        • Yadav P
        • Ng KP
        • Fenton A
        • Kyte D
        • Ferro CJ
        • Calvert M
        • Cockwell P
        • Stringer SJ
        Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study.
        PLoS One. 2016 Nov 10; 11e0165675
        • Sanders GD
        • Neumann PJ
        • Basu A
        • Brock DW
        • Feeny D
        • Krahn M
        • Kuntz KM
        • Meltzer DO
        • Owens DK
        • Prosser LA
        • Salomon JA
        • Sculpher MJ
        • Trikalinos TA
        • Russell LB
        • Siegel JE
        • Ganiats TG
        Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
        JAMA. 2016 Sep 13; 316: 1093-1103
        • Cui C
        • Ramakrishnan G
        • Murphy J
        • Malas MB
        Cost-Effectiveness of TransCarotid Artery Revascularization versus Carotid Endarterectomy.
        J Vasc Surg. 2021 Jun 25; S0741-5214 (1)01004
        • Prinssen M
        • Verhoeven EL
        • Buth J
        • Cuypers PW
        • van Sambeek MR
        • Balm R
        • Buskens E
        • Grobbee DE
        • Blankensteijn JD
        Dutch Randomized Endovascular Aneurysm Management (DREAM)Trial Group. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms.
        N Engl J Med. 2004 Oct 14; 351: 1607-1618
      1. Malas M, Freischlag J. Interpretation of the Results of OVER in the context of EVAR, DREAM and the EUROSTAR Registry. Semin Vasc Surg. 23(3):165–169.

        • Tengs TO
        • Wallace A
        One thousand health-related quality-of-life estimates.
        Med Care. 2000 Jun; 38: 583-637
        • Pecoraro F
        • Rancic Z
        • Lachat M
        • Mayer D
        • Amann-Vesti B
        • Pfammatter T
        • Bajardi G
        • Veith FJ
        Chronic mesenteric ischemia: critical review and guidelines for management.
        Ann Vasc Surg. 2013 Jan; 27: 113-122
        • Kanamori KS
        • Oderich GS
        • Fatima J
        • Sarac T
        • Cha S
        • Kalra M
        • De Martino R
        • Bower TC
        Outcomes of reoperative open or endovascular interventions to treat patients with failing open mesenteric reconstructions for mesenteric ischemia.
        J Vasc Surg. 2014 Dec; 60 (e1-2): 1612-1619
        • Silva JA
        • White CJ
        • Collins TJ
        • Jenkins JS
        • Andry ME
        • Reilly JP
        • Ramee SR
        Endovascular therapy for chronic mesenteric ischemia.
        J Am Coll Cardiol. 2006 Mar 7; 47: 944-950
        • Daliri A
        • Grunwald C
        • Jobst B
        • Szucs-Farkas Z
        • Diehm NA
        • Kickuth R
        • Do DD
        • Hoppe H
        Endovascular treatment for chronic atherosclerotic occlusive mesenteric disease: is stenting superior to balloon angioplasty?.
        Vasa. 2010 Nov; 39: 319-324
        • Turba UC
        • Saad WE
        • Arslan B
        • Sabri SS
        • Trotter S
        • Angle JF
        • Hagspiel KD
        • Kern JA
        • Cherry KJ
        • Matsumoto AH
        Chronic mesenteric ischaemia: 28-year experience of endovascular treatment.
        Eur Radiol. 2012 Jun; 22: 1372-1384
        • van Dijk LJD
        • Harki J
        • van Noord D
        • Verhagen HJM
        • Kolkman JJ
        • Geelkerken RH
        • Bruno MJ
        • Moelker A
        Dutch Mesenteric Ischemia Study group (DMIS). Covered stents versus Bare-metal stents in chronic atherosclerotic Gastrointestinal Ischemia (CoBaGI): study protocol for a randomized controlled trial.
        Trials. 2019 Aug 20; 20: 519
        • Oderich GS
        • Macedo R
        • Stone DH
        • Woo EY
        • Panneton JM
        • Resch T
        • Dias NV
        • Sonesson B
        • Schermerhorn ML
        • Lee JT
        • Kalra M
        • DeMartino RR
        • Sandri GA
        • Ramos Tenorio EJ
        Low Frequency Vascular Disease Research Consortium Investigators. Multicenter study of retrograde open mesenteric artery stenting through laparotomy for treatment of acute and chronic mesenteric ischemia.
        J Vasc Surg. 2018 Aug; 68: 470-480.e1
        • Andraska E
        • Haga L
        • Li X
        • Avgerinos E
        • Singh M
        • Chaer R
        • Madigan M
        • Eslami MH
        Retrograde open mesenteric stenting should be considered as the initial approach to acute mesenteric ischemia.
        J Vasc Surg. 2020 Oct; 72: 1260-1268
        • Ericsson A
        • Carlson E
        • Ching SS
        • Molassiotis A
        • Kumlien C
        Partners’ experiences of living with men who have screening-detected abdominal aortic aneurysms: A qualitative descriptive study.
        J Clin Nurs. 2020 Oct; 29: 3711-3720